5-Amino-1MQ and 10-Amino-1MQ: NNMT Inhibitor Pharmacology & Metabolic Research Sourcing Guide — plus Comparison to Tirzepatide, Semaglutide, and Other Metabolic Peptides

Research Guide | 2026-09-03 | 12 min read

Comprehensive research guide covering two nicotinamide N-methyltransferase (NNMT) inhibitors — 5-Amino-1MQ and 10-Amino-1MQ — including NNMT enzyme biology, NAD+ salvage pathway implications, white-fat browning research, comparison to incretin-pathway analogs (Tirzepatide, Semaglutide), and batch-level COA requirements for laboratory research programs.

Introduction: NNMT inhibition in metabolic research

Nicotinamide N-methyltransferase (NNMT) is a cytosolic methyltransferase that transfers a methyl group from S-adenosyl-L-methionine (SAM) to nicotinamide (the amide of vitamin B3), producing N1-methylnicotinamide (1-MN) and S-adenosyl-L-homocysteine (SAH). NNMT is expressed at high levels in white adipose tissue, liver, and several cancers, and it has emerged as a research target for adipocyte biology and NAD+-related metabolic pathways.

Two small-molecule NNMT inhibitors — 5-Amino-1MQ and 10-Amino-1MQ — anchor the laboratory NNMT-inhibition toolkit. Although both are small molecules rather than peptides, they are cataloged in the ZePeptide research-peptide platform because they are routinely sourced in the same metabolic-research procurement orders as Tirzepatide, Semaglutide, and AOD-9604, which together map the dominant receptor-and-enzyme mechanisms of obesity research.

NNMT Enzyme Biology

NNMT belongs to the methyltransferase superfamily. The enzyme is a 30 kDa monomer with a Rossmann-fold SAM-binding domain at the N-terminus and a nicotinamide-binding pocket at the C-terminus. Nicotinamide enters the active site, SAM donates a methyl group to the pyridine nitrogen, and the products (1-MN and SAH) are released. The cellular nicotinamide pool serves as the substrate for NAMPT, the rate-limiting enzyme of the NAD+ salvage pathway that recycles nicotinamide back to NAD+.

Inhibiting NNMT has two downstream consequences. The first is elevated cellular nicotinamide, which accelerates NAMPT-mediated NAD+ production. The second is reduced 1-MN production, which also disrupts methyl-group balance because each NNMT cycle consumes a SAM and produces an SAH.

5-Amino-1MQ and 10-Amino-1MQ Pharmacology

5-Amino-1MQ

5-Amino-1MQ is a small-molecule inhibitor (5-amino-1-methylquinolinium iodide, molecular weight 286.10 g/mol) of NNMT. The protonated quinolinium ring mimics the cationic nicotinamide substrate, binding the nicotinamide-binding pocket and competitively displacing nicotinamide. Cell-based IC50 values for 5-Amino-1MQ are typically in the 1-10 μM range depending on cell type and assay format. 5-Amino-1MQ is supplied as a yellow-green powder (the quinolinium chromophore) in an amber glass vial.

10-Amino-1MQ

10-Amino-1MQ is a structural analogue of 5-Amino-1MQ with a 4-aminopyrido substituent attached to the quinolinium core (molecular weight ~378 g/mol depending on counter-ion). The substituent contributes additional binding interactions with the nicotinamide-binding pocket and produces a higher-affinity inhibitor. Solubility is reduced compared to 5-Amino-1MQ, but the lower working concentration (~10x lower) compensates.

NAD+ Salvage Pathway Connections

NNMT inhibition increases the nicotinamide pool, which accelerates the NAMPT-mediated NAD+ salvage pathway. NAD+ is the substrate for sirtuin deacetylases (SIRT1-SIRT7) and PARP DNA repair enzymes. Elevated NAD+ therefore activates SIRT1/SIRT3 and downstream browning programs in white adipocytes. The end result of NNMT inhibition in animal models is increased beige-fat-program gene expression (Ucp1, Cidea, Prdm16), increased oxygen consumption, and improved glucose tolerance.

Comparison with Incretin-Pathway Modulators

Tirzepatide and Semaglutide are incretin-pathway agonists that work through hypothalamic and pancreatic receptors. They reduce food intake, slow gastric emptying, and increase insulin secretion through GIP/GLP-1 receptors. NNMT inhibitors work through entirely different mechanisms — adipose NAD+ metabolism and browning. The two classes are not redundant. Research laboratories often characterize them together to identify combined or synergistic metabolic effects in obesity-research models.

| Mechanism | Compound | Pathway | Primary Effect | |---|---|---|---| | Dual GIP/GLP-1 agonist | Tirzepatide | Incretin | Food intake, glucose, weight loss | | GLP-1 agonist | Semaglutide | Incretin | Food intake, glucose, weight loss | | NNMT inhibitor | 5-Amino-1MQ | NAD+ salvage | White-fat browning | | NNMT inhibitor | 10-Amino-1MQ | NAD+ salvage | White-fat browning (higher affinity) | | Lipolytic | AOD-9604 | Lipolysis | Adipocyte lipid release |

Quality Specifications Buyers Should Verify

NNMT inhibitor small molecules are characterized by:

• **HPLC purity** — ≥99% for 5-Amino-1MQ; ≥98% for 10-Amino-1MQ.
• **NMR identity** — 1H-NMR and 13C-NMR spectra versus reference standard.
• **Mass spectrometry identity** — within ±1 Da of theoretical.
• **Elemental analysis for iodine content** — for 5-Amino-1MQ iodide salt (theoretical ~44.4% iodide by mass).
• **Residual solvent analysis** — acetonitrile, methanol, dimethylformamide below ICH Q3C.
• **Lyophilization confirmation** — visual cake, moisture ≤5%, reconstitution note.
• **Storage condition** — amber glass vial, -20 °C, desiccation, light-protected.

ZePeptide ships both molecules as pre-weighed lyophilized solids in amber glass vials to protect against oxidation and photodegradation.

Research-Use Disclaimers

All molecules in this guide are supplied strictly for laboratory research. 5-Amino-1MQ, 10-Amino-1MQ, Tirzepatide, Semaglutide, and AOD-9604 are supplied for in-vitro, ex-vivo, and animal-model research only.

---

Research Disclaimer: This guide compiles published peer-reviewed metabolic pharmacology and analytical-chemistry references. It is intended for laboratory scientists sourcing research-grade NNMT inhibitors and metabolic peptides for in-vitro, ex-vivo, and animal-model studies. No content here constitutes medical or veterinary advice.

Note: All research peptides and compounds listed in this guide are intended for laboratory research purposes only and are not for human or animal consumption. Buyers are responsible for institutional approvals, biosafety committee registration, and applicable import/export compliance for the destination country.

ZePeptide content is for lawful laboratory and in-vitro research sourcing. Products are not supplied for human or veterinary use.